História da obesidade na classificação internacional de doenças (CID): de 1900 a 2018 / History of obesity in the international classification of diseases (ICD): 1900 to 2018

O presente artigo teve como objetivo descrever o histórico da inserção da condição clínica denominada atualmente de "obesidade" nas onze revisões da Classificação Internacional de Doenças (CID), publicadas pela Organização Mundial da Saúde (OMS), entre os anos 1900 e 2018. Para tanto, buscou-se pela palavra-chave "obesity" nos documentos, realizando, posteriormente, uma descrição e uma análise da presença, modo de inserção e as mudanças ocorridas ao longo do tempo. Os resultados demonstraram que a condição já foi e continua sendo inserida como sintoma, morbidade, coREVSmorbidade, causa de mortalidade e/ou doença. Concluiu-se que há uma grande inconsistência lógica nos princípios que regem a classificação.

This article aimed at describing the history of insertion of the clinical condition currently referred to as "obesity" in the eleven revisions of the International Classification of Diseases (ICD) published by the World Health Organization (WHO) between 1900 and 2018. For this purpose, a search for the keyword obesity was performed in the documents, with subsequent description and analysis of the presence, mode of insertion, and changes occurring over time. The results demonstrated that the condition has been and continues to be inserted as symptom, morbidity, comorbidity, cause of mortality and/or disease. It can be concluded that there is a massive logical inconsistency in the principles that govern the classification.

The Classification of Causes of Historical Mortality (CCHM): A proposal of the study of death records.

OBJECTIVE: To compare and contrast the Classification of Causes of Historical Mortality (CCHM) with the International Classification of Diseases 4th Revision (ICD-4) as methodological elements that can be implemented in historical mortality studies. MATERIALS AND METHODS: We conducted a longitudinal descriptive study of the causes of death in two different localities in Spain, namely, Cadiz and Vejer de la Frontera (1900-1950), to compare the International Classification of Diseases 4th Revision (ICD-4) and the Classification of Causes of Historical Mortality (CCHM). This study proposes the CCHM and its use in statistical analyses of mortality, especially from the mid-19th century to the second half of 20th century. It is a methodological instrument based on the theoretical precepts of Thomas McKeown, expanded through knowledge gained in studies of historical mortality and contrasted with editions of the ICD. RESULTS: The results showed several differences between the ICD-4 and the CCHM. The ten main causes of death (CoDs) in the CCHM account for 74.3% in Cadiz, compared to 56.6% accounted for by the ICD-4. According to the ICD-4, the number of infectious CoDs exceed the number of noninfectious ones in Cadiz every year. On the other hand, based on the CCHM, we observed that while infectious CoD causes of death predominated over noninfectious ones, there was a change in trend, with noninfectious CoDs predominating the following year. During the interval from 1915 to 1937 in Vejer de la Frontera, there were 12 deaths due to ill-specified causes (ICD-4: 18.200) and 0 due to ill-defined causes (CCHM: 3.0.0.0). CONCLUSIONS: The CCHM accurately determines the differences between infectious and noninfectious causes of death and explains sociodemographic and health-related aspects in the population and its use in employment, illegitimacy or place-of-death studies. Moreover, it has more advantages, such as the incorporation of new diagnostic expressions, and it can be constantly updated, thus facilitating its use over long periods of time.

De la neurastenia a la enfermedad postesfuerzo: evolución de los criterios diagnósticos del síndrome de fatiga crónica/encefalomielitis miálgica / From neurasthenia to post-exertion disease: Evolution of the diagnostic criteria of chronic fatigue syndrome/myalgic encephalomyelitis

Presentamos la evolución de la terminología y los criterios diagnósticos para el síndrome de fatiga crónica/encefalomielitis miálgica. Este síndrome es una entidad compleja y controvertida, de etiología desconocida, que aparece en la literatura médica en 1988, si bien desde el siglo XIX se identificaron cuadros clínicos de fatiga crónica idiopática con diferentes nombres, desde neurastenia, neuromiastenia epidémica y encefalomielitis miálgica benigna hasta la actual propuesta de enfermedad de intolerancia al esfuerzo (postesfuerzo). Todos ellos aluden a un estado crónico de fatiga generalizada de naturaleza desconocida, con limitaciones al esfuerzo físico y mental, acompañado de un conjunto de síntomas que comprometen diversos sistemas orgánicos. La Clasificación Internacional de Enfermedades (CIE-10) encuadra este síndrome en el apartado de trastornos neurológicos (G93.3), aunque todavía no se hayan encontrado hallazgos anatomopatológicos que lo clarifiquen. Se han documentado múltiples alteraciones orgánicas, pero no se ha establecido una biología común que aclare los mecanismos que subyacen a esta dolencia. Se enuncia como una disfunción neuroinmunoendocrina, con un diagnóstico exclusivamente clínico y por exclusión. Diversos autores han propuesto incluir el síndrome de fatiga crónica/encefalomielitis miálgica dentro de los síndromes de sensibilidad central, aludiendo a la sensibilización central como el sustrato fisiopatológico común para este síndrome y otros. El papel del médico de familia es clave en la enfermedad, para la detección de aquellos pacientes que presenten una fatiga de naturaleza desconocida que se prolonga de forma continua o intermitente durante más de 6 meses, al objeto de realizar un diagnóstico temprano y establecer un plan de actuación frente a una enfermedad crónica con unos altos niveles de morbilidad en la esfera física y mental. Objetivo: Realizar una revisión bibliográfica de la terminología y criterios diagnósticos del síndrome de fatiga crónica/encefalomielitis miálgica, al objeto de aclarar conceptualmente la enfermedad, como utilidad en el diagnóstico a los médicos de Atención Primaria

Changes in the terminology and diagnostic criteria for chronic fatigue syndrome/myalgic encephalomyelitis are explained in this paper. This syndrome is a complex and controversial entity of unknown origins. It appears in the medical literature in 1988, although clinical pictures of chronic idiopathic fatigue have been identified since the nineteenth century with different names, from neurasthenia, epidemic neuromyasthenia, and benign myalgic encephalomyelitis up to the current proposal of disease of intolerance to effort (post-effort). All of them allude to a chronic state of generalised fatigue of unknown origin, with limitations to physical and mental effort, accompanied by a set of symptoms that compromise diverse organic systems. The International Classification of Diseases (ICD-10) places this syndrome in the section on neurological disorders (G93.3), although histopathological findings have not yet been found to clarify it. Multiple organic alterations have been documented, but a common biology that clarifies the mechanisms underlying this disease has not been established. It is defined as a neuro-immune-endocrine dysfunction, with an exclusively clinical diagnosis and by exclusion. Several authors have proposed to include CFS/ME within central sensitivity syndromes, alluding to central sensitisation as the common pathophysiological substrate for this, and other syndromes. The role of the family doctor is a key figure in the disease, from the detection of those patients who present a fatigue of unknown nature that is continuous or intermittent for more than 6 months, in order to make an early diagnosis and establish a plan of action against a chronic disease with high levels of morbidity in the physical and mental sphere. Objective: To carry out a bibliographic review of the terminology and diagnostic criteria of the chronic fatigue syndrome/myalgic encephalomyelitis, in order to clarify the pathology conceptually, as a usefulness in the diagnosis of Primary Care physicians

Are outcome measures in allergic diseases relevant for the WHO's International Classification of Diseases in allergology?

PURPOSE OF REVIEW: To review and understand the impact of the outcome measures of allergic and hypersensitivity conditions for the WHO's International Classification of Diseases (ICD) and its impact in the management of anaphylaxis and identify potential strategies to improve patients' care and prevention. RECENT FINDINGS: The pioneer chapter addressed to allergic and hypersensitivity conditions in the 11th version of the WHO's ICD is the result of the evidence-based academic technical actions consistently following of collaborations of the allergy community and integrated international initiatives in order to reach quality outcomes measures of allergies worldwide. SUMMARY: Allergic and hypersensitivity conditions are increasing worldwide, however, they have never been well represented in the international classification systems, such as the ICD. The ALLERGY in ICD-11 initiative has been launched in 2012 in order to gather a better representation of these conditions in the ICD-11. As a result of the evidence-based academic technical actions acknowledged by the Joint Allergy Academies and the WHO, the pioneer chapter Allergy and hypersensitivity conditions has been constructed. This framework can be considered a milestone in the history of the allergy specialty. More reliable, accurate and comparable epidemiological data will be able to provide a big picture of these conditions and will support improvements in many levels of the health system. As knowledge derived from populations is key information for more realistic decision-making, the construction of the new section addressed to allergic and hypersensitivity conditions in the ICD-11 will allow the collection of more accurate epidemiological data to support quality management of patients, and better facilitate healthcare planning to implement public health measures to prevent and reduce the morbidity and mortality attributable to these conditions.

Nomenclature for congenital and paediatric cardiac disease: the International Paediatric and Congenital Cardiac Code (IPCCC) and the Eleventh Iteration of the International Classification of Diseases (ICD-11).

An internationally approved and globally used classification scheme for the diagnosis of CHD has long been sought. The International Paediatric and Congenital Cardiac Code (IPCCC), which was produced and has been maintained by the International Society for Nomenclature of Paediatric and Congenital Heart Disease (the International Nomenclature Society), is used widely, but has spawned many "short list" versions that differ in content depending on the user. Thus, efforts to have a uniform identification of patients with CHD using a single up-to-date and coordinated nomenclature system continue to be thwarted, even if a common nomenclature has been used as a basis for composing various "short lists". In an attempt to solve this problem, the International Nomenclature Society has linked its efforts with those of the World Health Organization to obtain a globally accepted nomenclature tree for CHD within the 11th iteration of the International Classification of Diseases (ICD-11). The International Nomenclature Society has submitted a hierarchical nomenclature tree for CHD to the World Health Organization that is expected to serve increasingly as the "short list" for all communities interested in coding for congenital cardiology. This article reviews the history of the International Classification of Diseases and of the IPCCC, and outlines the process used in developing the ICD-11 congenital cardiac disease diagnostic list and the definitions for each term on the list. An overview of the content of the congenital heart anomaly section of the Foundation Component of ICD-11, published herein in its entirety, is also included. Future plans for the International Nomenclature Society include linking again with the World Health Organization to tackle procedural nomenclature as it relates to cardiac malformations. By doing so, the Society will continue its role in standardising nomenclature for CHD across the globe, thereby promoting research and better outcomes for fetuses, children, and adults with congenital heart anomalies.

El trastorno de Tourette a lo largo de la historia / Tourette’s disorder in history

El término trastorno de Tourette emerge en el campo de la psiquiatría con la aparición de la tercera edición del Manual Diagnóstico y Estadístico de Trastornos Mentales (DSM-III) en el año 1980. Sin embargo, el hecho de que se consensuaran sus criterios diagnósticos por el grupo de expertos responsable de la elaboración de dicha versión del DSM no implica que previamente no existieran múltiples referencias a su sintomatología. El objetivo de este trabajo es recoger aportaciones de la historia de la neurología y de la psiquiatría que permitan comprender cómo se ha ido configurando el concepto operativo de trastorno de Tourette tal como es aceptado en la actualidad por una gran parte de la comunidad científica. En la última década, merced a los estudios de asociación de todo el genoma, se han producido importantes avances en la identificación de variantes comunes y variantes raras implicadas en la etiología del trastorno de Tourette. La conclusión más relevante que se desprende de esta revisión es poner al descubierto la crisis del modelo categórico kraepeliniano del trastorno (AU)

The term Tourette’s disorder emerged in the field of psychiatry with the appearance of the third edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-III) in 1980. However, the fact that some diagnostic criteria were agreed by the expert group responsible for the development of this version of the DSM diagnostic criteria does not mean that multiple references to the symptoms of the disorder did not previously exist. The aim of this review is to collect contributions from the history of neurology and psychiatry which allow us to understand how the operating concept of Tourette’s disorder has been progressively shaped as it is currently accepted by the scientific community. In the last decade, thanks to studies of genome association, major advances have arisen in identifying common variants and rare variants involved in the etiology of Tourette’s disorder. The most important conclusion of this review is the disclosure of the crisis of the Kraepelinian categorical model of the disorder (AU)

ICD-10: History and Context.

In recent months, organized medicine has been consumed by the anticipated transition to the 10th iteration of the International Classification of Disease system. Implementation has come and gone without the disruptive effects predicted by many. Despite the fundamental role the International Classification of Disease system plays in health care delivery and payment policy, few neuroradiologists are familiar with the history of its implementation and implications beyond coding for diseases.

Re-evaluating DSM-I.

The DSM-I is currently viewed as a psychoanalytic classification, and therefore unimportant. There are four reasons to challenge the belief that DSM-I was a psychoanalytic system. First, psychoanalysts were a minority on the committee that created DSM-I. Second, psychoanalysts of the time did not use DSM-I. Third, DSM-I was as infused with Kraepelinian concepts as it was with psychoanalytic concepts. Fourth, contemporary writers who commented on DSM-I did not perceive it as psychoanalytic. The first edition of the DSM arose from a blending of concepts from the Statistical Manual for the Use of Hospitals of Mental Diseases, the military psychiatric classifications developed during World War II, and the International Classification of Diseases (6th edition). As a consensual, clinically oriented classification, DSM-I was popular, leading to 20 printings and international recognition. From the perspective inherent in this paper, the continuities between classifications from the first half of the 20th century and the systems developed in the second half (e.g. DSM-III to DSM-5) become more visible.

[Are the current concepts of obsessive disorders a novelty? From Westphal (1877) and Thomsen (1895) to ICD-10 and DSM-5]. / Sind die aktuellen Konzepte der Zwangsstörung ein Novum? Von Westphal (1877) und Thomsen (1895) zur ICD-10 und zum DSM-5.

In German-speaking countries it was Carl Westphal who in 1877 offered the first precise definition of obsessive ideas and distinguished obsessive compulsive disorder (OCD) as an independent disorder in its own right. The criteria mentioned by him for establishing OCD gave rise to a debate on the character and classification of OCD but were not fully acknowledged by his colleagues at the time. In 1895 Westphal's student Robert Thomsen tried to substantiate all points in his teacher's theory that had raised criticism. Thus the works by Westphal and Thomsen are most relevant for the current conceptualization and definition of OCD, for they laid the basis for the present phenomenology, definition and classification of OCD according to ICD-10 and DSM-5. Apart from phenomenologically differentiating between obsessions (i.e. obsessive thoughts and impulses) and compulsions (i.e. compulsive actions and inhibitions), Westphal and Thomsen also laid the basis for most of the current diagnostic criteria. Thomsen led the way to current classifications by subdifferentiating OCD as an illness on its own on the one hand and obsessions and compulsions as symptoms accompanying other conditions on the other.

ICD coding for epilepsy: past, present, and future--a report by the International League Against Epilepsy Task Force on ICD codes in epilepsy.

The World Health Organization (WHO) International Classification of Diseases (ICD) has been used to classify causes of morbidity and mortality such as epilepsy for more than 50 years. The aims of this critical commentary are to do the following: (1) Introduce the ICD classification, summarize the ICD-9 and ICD-10 codes for epilepsy and seizures, and discuss the challenges of mapping epilepsy codes between these two versions; (2) discuss how the ICD-9 and ICD-10 relate to the revised International League Against Epilepsy (ILAE) terminology and concepts for classification of seizures and epilepsies; (3) discuss how ICD-coded data have been used for epilepsy care and research and briefly examine the potential impact of the international ICD-10 clinical modifications on research; (4) discuss the upcoming ICD-11 codes and the role of the epilepsy community in their development; and (5) discuss how the ICD-11 will conform more closely to the current ILAE terminology and classification of the epilepsies and seizures and its potential impact on clinical care, surveillance, and public health and research.

[Introduction and transformation of the psychiatric term "anancasm". From Gyula (Julius) Donáth via Kurt Schneider to ICD-10]. / Einführung und Wandlung des psychiatrischen Terminus "Anankasmus". Von Gyula (Julius) Donáth über Kurt Schneider bis zur ICD-10.

The conceptual history of "anancasm" in psychiatry remains almost unexplored and this article will help to remove this deficit. It was the Budapest-based neuropsychiatrist Gyula Donáth (1849-1944) who first proposed this Greek-rooted term in 1897 as an international term for compulsive symptoms and as an independent mental illness similar to present-day obsessive compulsive disorders (ICD-10). By suggesting this term Donáth wanted to extend the concept of compulsion as proposed by his teacher Carl Westphal to other compulsive phenomena, psychomotor impulses and restrictions including echolalia, coprolalia, echokinesis, echopraxia, contemporary maladie des tics (present day Tourette's syndrome) and even intermittent dipsomania (craving for alcohol), paraphilias, sexual fetishes and homosexuality. In 1923 Kurt Schneider used this term for a subgroup of psychopathic personalities, the so-called insecure anancastic psychopaths. His concept was much different to that suggested by Donáth, with the only thing in common being the compulsory component. Schneider's anancasts suffered from feelings of insecurity and insufficiency and were forced to try to overcompensate by being excessively careful, meticulous and hyper-correct. Based on Schneider's concept anancasm has survived as a name for a subdivision of compulsive personality disorders in ICD-10; however, these rather complex personality defects were not what Donáth had in mind when he first suggested the term anancasm. The paper discusses further discrepancies between Donáth, Schneider and ICD-10.

[The International Classification of Diseases, the Family of International Classifications, the ICD-11, and post-polio syndrome]. / A Classificação Internacional de Doenças, a Família de Classificações Internacionais, a CID-11 e a Síndrome Pós-Poliomielite.

The first International Classification of Diseases (ICD) was approved in 1893 and since then it has been periodically reviewed. The last, 10th revision (ICD-10), was approved in 1989. Since 1989, it was possible to update from ICD revisions, which did not happen before. The next revision (ICD-11) would probably be published in 2015. In 1989, mechanisms were established to update ICD-10, through the creation of the Morbidity Reference Group (MbRG) in 1997 and the Update and Revision Committee (URC) in 2000. The Morbidity Reference Group (MbRG) was created in 2007 to discuss in more detail the issues to update morbidity. A specific code in ICD was not included in the revision of ICD-10 in 1989 for the post-polio syndrome (PPS). However, the ICD new code G14 for PPS was included in ICD-10 since 2010.

DSM-5: historical perspectives.

The first major attempts to categorize psychiatric disorders in the United States occurred in the mid-1800s, when census data were collected that included "insanity" and "idiocy" of household members. In Europe, Florence Nightingale promoted the use of non-fatal disease classification for morbidity and treatment in 1860. By the late 1800s, Kraepelin categorized disorders, and his sixth edition of the Compendium der Psychiatrie was widely adopted by both Europeans and Americans. In 1952, the American Psychiatric Association published the first edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM). Since then, the manual has been periodically updated, expanded, and edited to reflect social and scientific beliefs about the etiology and categorization of psychiatric illness and care. In this article, we explore the historical and ongoing development of the DSM and its implications for psychiatric nurses.

An overview and profile of the ICF's use in Brazil--a decade of history.

BACKGROUND: In 2001 the World Health Organization (WHO) adopted a classification system for understanding functioning and human disability: the International Classification of Functioning, Disability and Health (ICF). The ICF's acceptance and use has been facilitated by the development and global consensus process, with increasing evidence about its validity. OBJECTIVES: To investigate the overview of the use of the ICF in Brazil, since its conception in 2001 until the year 2011. METHOD: We conducted an integrative literature review by searching SciELO, Lilacs, PubMed and ISI databases. To be included in the review, the study must have been published as scientific article, editorial or technical note, and had to having the participation of Brazilian researchers or have been developed in Brazil. RESULTS: One hundred and two publications were identified, but only 47 studies were included based in the inclusion criteria. Most of eligible studies were related to neurology (n=16) and orthopaedics (n=12) subdisciplines. The university that most appeared in the publications in national journals was The Universidade de São Paulo (11) and in the international journals was Universidade Federal de Minas Gerais (4). In 2003 there was only one publication; in 2010 and 2011 were 10 and 8, respectively. CONCLUSIONS: Although incipient, the use of ICF in the Brazilian scientific community is rising. There is a concentration of studies related to the locomotor system, as well as performed by universities in the southeast area of Brazil.

An overview and profile of the ICF's use in Brazil - a decade of history / Panorama e perfil da utilização da CIF no Brasil : uma década de história

BACKGROUND: In 2001the World Health Organization (WHO) adopted a classification system for understanding functioning and human disability: the International Classification of Functioning, Disability and Health (ICF). The ICF’s acceptance and use has been facilitated by the development and global consensus process, with increasing evidence about its validity. OBJECTIVES: To investigate the overview of the use of the ICF in Brazil, since its conception in 2001 until the year 2011. METHOD: We conducted an integrative literature review by searching SciELO, Lilacs, PubMed and ISI databases. To be included in the review, the study must have been published as scientific article, editorial or technical note, and had to having the participation of Brazilian researchers or have been developed in Brazil. RESULTS: One hundred and two publications were identified, but only 47 studies were included based in the inclusion criteria. Most of eligible studies were related to neurology (n=16) and orthopaedics (n=12) subdisciplines. The university that most appeared in the publications in national journals was The Universidade de São Paulo (11) and in the international journals was Universidade Federal de Minas Gerais (4). In 2003 there was only one publication; in 2010 and 2011 were 10 and 8, respectively. CONCLUSIONS: Although incipient, the use of ICF in the Brazilian scientific community is rising. There is a concentration of studies related to the locomotor system, as well as performed by universities in the southeast area of Brazil.

CONTEXTUALIZAÇÃO: Em 2001, a OMS aprovou um sistema de classificação para o entendimento da funcionalidade e da incapacidade humana: a Classificação Internacional de Funcionalidade, Incapacidade e Saúde (CIF). A aceitação e a utilização da CIF vêm sendo facilitadas pelo seu desenvolvimento e processo de consenso global, com crescente evidência sobre a sua validade. OBJETIVOS: Investigar o panorama do uso da CIF no Brasil desde a sua concepção em 2001 até o ano de 2011. MÉTODO: Revisão integrativa da literatura com consulta às bases de dados SciELO, Lilacs, PubMed e ISI. Para ser incluído na revisão, o trabalho deveria ter sido publicado na forma de artigo científico, editorial ou nota técnica, além de ter a participação de pesquisadores nacionais ou ter sido desenvolvido no Brasil. RESULTADOS: Foram identificadas 102 publicações; em seguida, a partir dos critérios de seleção, foram analisados 47 estudos, sendo a sua maioria nas áreas de neurologia (16) e ortopedia (12). A instituição de ensino que mais aparece nas publicações em periódicos nacionais é a USP (11) e, em internacionais, é a UFMG (4). Em 2003, houve apenas uma publicação, já em 2010, foram dez e, em 2011, oito. CONCLUSÕES: Apesar de incipiente, o uso da CIF na comunidade científica brasileira está em ascensão. Há uma concentração de estudos nas áreas relacionadas ao aparelho locomotor bem como nas instituições da região sudeste.

[Classifications, agreements and negotiations: bases for the first international statistics on mental diseases (Paris 1889)]. / Clasificaciones, acuerdos y negociaciones: bases de la primera estadística internacional de enfermedades mentales (Paris, 1889).

This article discusses the construction of the first international classification of mental diseases, specifically created to allow a unified statistics on the mentally ill. This classification was discussed and approved at the International Congress of Mental Medicine held in Paris in August 1889, in response to a request made by the Society of Mental Medicine of Belgium four years earlier. A careful reading of this report helps us to understand the role of the classification and statistics of pathologies in the field of psychiatric medicine. This offers an historical perspective on an issue that remains problematic and allows analysis of the time when psychiatric classifications were first articulated and subjected to comparative statistical study.

Classifying external causes of injury: history, current approaches, and future directions.

The International Classification of Diseases (ICD) is used to categorize diseases, injuries, and external causes of injury, and it is a key epidemiologic tool enabling storage and retrieval of data from health and vital records to produce core international mortality and morbidity statistics. The ICD is updated periodically to ensure the classification system remains current, and work is now under way to develop the next revision, ICD-11. It has been almost 20 years since the last ICD edition was published and over 60 years since the last substantial structural revision of the external causes chapter. Revision of such a critical tool requires transparency and documentation to ensure that changes made to the classification system are recorded comprehensively for future reference. In this paper, the authors provide a history of the development of external causes classification and outline the external cause structure. They discuss approaches to manage ICD-10 deficiencies and outline the ICD-11 revision approach regarding the development of, rationale for, and implications of proposed changes to the chapter. Through improved capture of external cause concepts in ICD-11, a stronger evidence base will be available to inform injury prevention, treatment, rehabilitation, and policy initiatives to ultimately contribute to a reduction in injury morbidity and mortality.